Your browser doesn't support javascript.
loading
ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
Mareckova, Andrea; Malcikova, Jitka; Tom, Nikola; Pal, Karol; Radova, Lenka; Salek, David; Janikova, Andrea; Moulis, Mojmir; Smardova, Jana; Kren, Leos; Mayer, Jiri; Trbusek, Martin.
Afiliação
  • Mareckova A; a Department of Internal Medicine - Hematology and Oncology , University Hospital Brno and Faculty of Medicine, Masaryk University , Brno , Czech Republic.
  • Malcikova J; a Department of Internal Medicine - Hematology and Oncology , University Hospital Brno and Faculty of Medicine, Masaryk University , Brno , Czech Republic.
  • Tom N; b Central European Institute of Technology (CEITEC), Center of Molecular Medicine, Masaryk University , Brno , Czech Republic.
  • Pal K; b Central European Institute of Technology (CEITEC), Center of Molecular Medicine, Masaryk University , Brno , Czech Republic.
  • Radova L; b Central European Institute of Technology (CEITEC), Center of Molecular Medicine, Masaryk University , Brno , Czech Republic.
  • Salek D; a Department of Internal Medicine - Hematology and Oncology , University Hospital Brno and Faculty of Medicine, Masaryk University , Brno , Czech Republic.
  • Janikova A; a Department of Internal Medicine - Hematology and Oncology , University Hospital Brno and Faculty of Medicine, Masaryk University , Brno , Czech Republic.
  • Moulis M; c Department of Pathology, University Hospital Brno and Faculty of Medicine , Masaryk University , Brno , Czech Republic.
  • Smardova J; c Department of Pathology, University Hospital Brno and Faculty of Medicine , Masaryk University , Brno , Czech Republic.
  • Kren L; c Department of Pathology, University Hospital Brno and Faculty of Medicine , Masaryk University , Brno , Czech Republic.
  • Mayer J; a Department of Internal Medicine - Hematology and Oncology , University Hospital Brno and Faculty of Medicine, Masaryk University , Brno , Czech Republic.
  • Trbusek M; a Department of Internal Medicine - Hematology and Oncology , University Hospital Brno and Faculty of Medicine, Masaryk University , Brno , Czech Republic.
Leuk Lymphoma ; 60(6): 1420-1428, 2019 06.
Article em En | MEDLINE | ID: mdl-30626249
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Predisposição Genética para Doença / Linfoma de Célula do Manto / Proteínas Mutadas de Ataxia Telangiectasia / Mutação Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Predisposição Genética para Doença / Linfoma de Célula do Manto / Proteínas Mutadas de Ataxia Telangiectasia / Mutação Idioma: En Ano de publicação: 2019 Tipo de documento: Article